Prestige Consumer director granted 2,981 RSUs

ZIER DAWN M. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

ZIER DAWN M. reported acquisition or exercise transactions in this Form 4 filing.

Prestige Consumer Healthcare Inc. reported that director Dawn M. Zier received a grant of 2,981 restricted stock units, calculated as $155,000 divided by the $52.00 closing share price on August 4, 2026, under the director compensation program. The RSUs vest on the first anniversary of grant and will be settled in one share of common stock per unit after vesting upon the earliest of the director’s death, separation, or a change in control, and her directly held common stock position is now 19,514 shares.

Insider Trade Summary

Grant/Award: 2,981 shares

Grant/Award 1 txn

Insider ZIER DAWN M.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share F1	2,981	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 19,514 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.

Key Figures

RSUs granted: 2,981 restricted stock units Award value: $155,000 Reference share price: $52.00 +1 more

4 metrics

RSUs granted 2,981 restricted stock units Equity award to director Dawn M. Zier on August 4, 2026

Award value $155,000 Equity value used to determine the number of RSUs granted

Reference share price $52.00 Closing stock price on August 4, 2026 used to calculate RSUs

Shares following transaction 19,514 shares Director’s reported direct common stock holdings after the award

Key Terms

restricted stock units, director compensation program, change in control

3 terms

restricted stock units financial

"The Reporting Person received 2,981 restricted stock units equal to $155,000"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

director compensation program financial

"in connection with the Issuer's director compensation program"

change in control regulatory

"promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did Prestige Consumer (PBH) grant to director Dawn M. Zier?

Dawn M. Zier received 2,981 restricted stock units (RSUs) from Prestige Consumer Healthcare. The grant was part of the company’s director compensation program and represents a right to receive one share of common stock for each RSU upon settlement after vesting and trigger events.

How was the 2,981-unit RSU grant for Prestige Consumer (PBH) calculated?

The 2,981 RSUs were calculated by dividing an equity value of $155,000 by the company’s $52.00 closing stock price on August 4, 2026. This formula determined the number of units granted under the director compensation program.

When do Dawn M. Zier’s Prestige Consumer (PBH) RSUs vest and settle?

The RSUs vest on the first anniversary of the grant date. After vesting, they are settled in one share of common stock per unit, delivered promptly following the earliest of the director’s death, separation from service, or a change in control.

What are Dawn M. Zier’s reported Prestige Consumer (PBH) holdings after this grant?

Following the award, Dawn M. Zier is reported to directly hold 19,514 shares of Prestige Consumer Healthcare common stock. This figure reflects her direct ownership position after the RSU grant disclosed in the insider transaction report.

Was Dawn M. Zier’s RSU grant at Prestige Consumer (PBH) reported under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox was not marked as affirming a trading plan. The transaction is described as a grant under the issuer’s director compensation program, without additional plan-related details in the disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 04:09 PM Accepted by SEC EDGAR 08/05/2026 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZIER DAWN M.

(Last) (First) (Middle)

660 WHITE PLAINS ROAD

(Street)

TARRYTOWN NEW YORK 10591

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	08/04/2026		A		2,981(1)	A	$0	19,514	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.

	/s/ Dawn M. Zier by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney dated May 4, 2020 on file with the Commission	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)